Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01302652 · ClinicalTrials.gov registry record
Effect of Growth Hormone (GH) on Cardiac Echos in GH Deficient Patients After Acromegaly Treatment
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 20
- Enrollment target
NCT01302652: Completed study, sponsored by Massachusetts General Hospital.
NCT01302652 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01302652 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this research study is to study the effects of growth hormone (GH) replacement on the heart. The investigators will study these effects in people who have been cured of acromegaly and then have developed growth hormone deficiency (GHD, not enough growth hormone).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-02 |
| Est. Completion | 2015-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01302652
The ClinicalTrials.gov registry entry for NCT01302652 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01302652 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01302652 about?
NCT01302652 is a clinical study titled "Effect of Growth Hormone (GH) on Cardiac Echos in GH Deficient Patients After Acromegaly Treatment". The purpose of this research study is to study the effects of growth hormone (GH) replacement on the heart. The investigators will study these effects in people who have been cured of acromegaly and then have developed growth hormone deficiency (GHD, not enough growth hormone).
What is the current status of trial NCT01302652?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2011-02. Estimated completion is 2015-02.
Who is sponsoring clinical trial NCT01302652?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.